OTEZLA (Apremilast) Phase III Data Showed Significant Improvements in P
RELIEF™ trial demonstrated statistically significant reductions in ora...
2018-02-25
文传商讯
Oral OTEZLA (Apremilast) Demonstrated Significant Improvement versus Pl
Data from UNVEIL, the first trial of patients with moderate plaque psoriasis...
2017-03-06
文传商讯
Celgene to Present New Data from Clinical Trials on Oral OTEZLA (apremi
UNVEIL evaluated the efficacy and safety of oral OTEZLA at 16 weeks in patie...
2017-03-06
文传商讯
Oral PDE-4 Inhibitor, OTEZLA, Approved for the Treatment of Plaque Psor
The first oral treatment in 25 years for patients in Japan with these diseas...
2016-12-23
文传商讯
Data on Early Onset of Efficacy for Oral OTEZLA (apremilast) in Active
ACTIVE trial in biologic-naïve patients met its primary endpoint, demon...
2016-11-16
文传商讯
Oral OTEZLA® (apremilast) Data from Open-Label Phase of ESTEEM and
Pooled ESTEEM 1 and 2 182-week data will report on long-term exposure of OT...
2016-03-08
文传商讯
